Product Information

LEVONOR-ETH ESTRAD 0.1-0.02 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1509 per EA under NDC 68180085473. Its NADAC has been published 345 times since Jan 15, 2020.

FDA first approved this application on Jan 18, 2013. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVONOR-ETH ESTRAD 0.1-0.02 MG

Levonorgestrel and Ethinyl Estradiol
$0.1509per EA

NDC

68180085473

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091425

FDA Approved

1/18/2013

TE Code

AB1

On Market Since

7/3/2019

Price Statistics

The NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has been published 345 times since Jan 15, 2020, and over the history we have for it it has declined 51.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1509 per EA
All-time high$0.3372 (Jun 10, 2020)
All-time low$0.1212 (Jul 17, 2024)
52-week high$0.1741
52-week low$0.1509
Median price$0.1937
Average price$0.1985
Largest weekly change+35.3% (Jun 19, 2024)
Weeks tracked345
Tracking sinceJan 15, 2020

Price History

1W

-1.1%

1M

-1.1%

3M

-3.0%

6M

-7.5%

1Y

-4.7%

3Y

-17.9%

5Y

-29.0%

All

-51.0%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LEVONOR-ETH ESTRAD 0.1-0.02 MG?

The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.1-0.02 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.1509 per EA (NDC 68180085473), effective Aug 19, 2026.

How has the price of LEVONOR-ETH ESTRAD 0.1-0.02 MG changed over time?

Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has declined 51.0%. It has been tracked across 345 weekly CMS publications since Jan 15, 2020.

What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.1-0.02 MG?

Since Jan 15, 2020, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.3372 (Jun 10, 2020), with a median of $0.1937 per EA.

Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.1-0.02 MG?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 25% below LEVONOR-ETH ESTRAD 0.1-0.02 MG.

Who manufactures LEVONOR-ETH ESTRAD 0.1-0.02 MG?

LEVONOR-ETH ESTRAD 0.1-0.02 MG (NDC 68180085473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.